Presentations from 35th Annual International Prostate Cancer Update
Update on Telesurgery and Novel Robotic Systems
David M. Albala, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 9, 2025, in Vail, Colorado.
Transurethral Ultrasound Guided Prostate Ablation (TULSA): Clinical Trials and Real-world Results
Christian P. Pavlovich, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 9, 2025, in Vail, Colorado.
Current Advances of Liquid Biopsies in Prostate Cancer
Edwin M. Posadas, MD, FACP, presented this lecture during the 35th Annual International Prostate Cancer Update on February 9, 2025, in Vail, Colorado.
MRI-Assisted Radiosurgery (MARS) Management of High Risk and Recurrent Prostate Cancer
Steven J. Frank, MD, FACR, FABS, FASTRO, presented this lecture during the 35th Annual International Prostate Cancer Update on February 9, 2025, in Vail, Colorado.
Panel Discussion: TechCon: Novel and New Technologies in Prostate Cancer
John W. Davis, MD, FACS, and Andrew W. Hahn, MD, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 9, 2025, in Vail, Colorado.
Biochemical Recurrence after Radical Prostatectomy
Christian P. Pavlovich, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Optimizing Utilization of PSMA PET into a Urological Practice
David M. Albala, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Treating Oligometastatic Prostate Cancer in the PSMA PET Era
Andrew W. Hahn, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Reducing Imaging Denials: LUGPA Perspectives
Ronald P. Kaufman, Jr., MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Panel Discussion: Molecular Targeted Imaging (MTI)
A. Oliver Sartor, MD and Brian Helfand, MD, PhD, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Update: Studies Combining Secondary Biomarkers and MRI
Leonard G. Gomella, MD, FACS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Biopsy Updates: Do We Have Clarity?
Ronald P. Kaufman, Jr., MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Secondary Biomarkers for Prostate Cancer Clinical Overview 2025
Christian P. Pavlovich, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Panel Discussion: Advances in Testing and Diagnosis
Leonard G. Gomella, MD, FACS, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Identification and Management of High-Risk Screening Populations
Brian T. Helfand, MD, PhD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Prostate Cancer Management Decisions From Germline and Somatic Testing
Leonard G. Gomella, MD, FACS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Updates on Global Screening Trials Where Are We Headed Next
R. Jonathan Henderson, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Grade Group 1 at Biopsy—Do We Need to Know More?
John W. Davis, MD, FACS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Panel Discussion: Germline, Molecular Detection, and Screening
J. Ryan, MD, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
The Evolution of Genetic Testing in the Management of Prostate Cancer
Leonard G. Gomella, MD, FACS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Genomic Biomarker Roundtable
Leonard G. Gomella, MD, FACS, and Brian T. Helfand, MD, PhD, moderated this roundtable discussion during the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
The Undecided PCA Consult: Optimized Counseling, Treatment Choices, Avoiding Decision Regret
Jonathan D. Tward, MD, PhD, FASTRO, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Localized Prostate Cancer
Jason A. Efstathiou, MD, DPhil, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Lessons Learned from High Impact Randomized Trials
Mira Keyes MD, FRCPC, FABS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Panel Discussion: Approaches in Local Therapy for Prostate Cancer
Peter F. Orio III, DO, MS, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Brian J. Moran Distinguished Lecture: Brian Moran – An Unmatched Legacy of Permanent Prostate Brachytherapy
Brian J. Davis, MD, PhD, FABS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Focal Therapy Clinical Trials – Concepts and Challenges
Steven J. Frank, MD, FACR, FABS, FASTRO, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Focal Therapies for Prostate Cancer: Recurrent versus Persistent Disease Management
Brian T. Helfand, MD, PhD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Focal Brachytherapy in 2025
Peter J. Rossi, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Panel Discussion: Focal Therapy
John W. Davis, MD, FACS, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
Prostate Cancer in the Veteran Population Roundtable
Peter F. Orio III, DO, MS, moderated this roundtable discussion at the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Challenging the Role of Pelvic Lymph Node Dissection at Robotic Prostatectomy
John W. Davis, MD, FACS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Pelvic Lymph Node Management: Radiation Approach
Jason A. Efstathiou, MD, DPhil, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Staging Updates: Whole Body MRI and PET Imaging for Prostate Cancer
Brian T. Helfand, MD, PhD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
ADT and Radiation
Mira Keyes MD, FRCPC, FABS, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Panel Discussion: High Risk Localized and Oligometastatic Disease
Charles J. Ryan, MD, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
mHSPC : Latest Approaches and Clinical Trials
Tanya B. Dorf, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
PARP in mCRPC
Daniel P. Petrylak, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
New Concepts in Molecularly Targeted Radiation in Prostate Cancer
Oliver Sartor, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Advanced Prostate Cancer Clinics (APCC): LUGPA Perspective
Ronald P. Kaufman, Jr., MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 11, 2025, in Vail, Colorado.
Panel Discussion: Advanced Prostate Cancer: Part 1
Brian J. Davis, MD, PhD, moderated this panel discussion at the 35th Annual International Prostate Cancer Update on February 10, 2025, in Vail, Colorado.
ARPi Combinations in mCRPC
Tanya B. Dorf, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.
Advanced Prostate Cancer: When and How to Radiate
Jason A. Efstathiou, MD, DPhil, presented this lecture during the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.
Future of AR-Directed Therapy
Andrew W. Hahn, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.
Ongoing Clinical Trials Update
Daniel P. Petrylak, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.
A Review of Prostate Cancer Perirectal Spacers
Jonathan D. Tward, MD, PhD, FASTRO, presented this lecture during the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.
Prediction of Extraprostatic Disease: Updates on NeuroSAFE, Histologic Scanner, Conventional Nomograms/Imaging, & AI-Assisted Prostate Cancer Mapping
David M. Albala, MD, presented this lecture during the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.
Expert Panel: Which Patients Do You Struggle With the Most, and What Makes You Sweat?
John W. Davis, MD, FACS, moderated this expert panel discussion at the 35th Annual International Prostate Cancer Update on February 12, 2025, in Vail, Colorado.